These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8831915)

  • 1. Lipids and atherogenesis in diabetes mellitus.
    Betteridge DJ
    Atherosclerosis; 1996 Jul; 124 Suppl():S43-7. PubMed ID: 8831915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.
    Woodman RJ; Chew GT; Watts GF
    Drugs; 2005; 65(1):31-74. PubMed ID: 15610050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus.
    Ginsberg HN; Illingworth DR
    Am J Cardiol; 2001 Sep; 88(6A):9H-15H. PubMed ID: 11576520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
    Goa KL; Barradell LB; Plosker GL
    Drugs; 1996 Nov; 52(5):725-53. PubMed ID: 9118820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of diabetic dyslipidemia.
    Garg A
    Am J Cardiol; 1998 Feb; 81(4A):47B-51B. PubMed ID: 9526814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic dyslipidaemia: current treatment recommendations.
    Best JD; O'Neal DN
    Drugs; 2000 May; 59(5):1101-11. PubMed ID: 10852642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes mellitus as a risk factor for arteriosclerosis].
    Maeda E; Yoshino G; Kasuga M
    Nihon Rinsho; 1993 Aug; 51(8):2170-6. PubMed ID: 8411688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coronary arteriosclerosis and lipid metabolism (hyperlipemia)].
    Nakamura H
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():69-74. PubMed ID: 12734955
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of lipids and type 2 diabetes.
    Hermayer KL
    Curr Cardiol Rep; 2004 Nov; 6(6):443-50. PubMed ID: 15485606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic dyslipidaemia: treatment implications.
    Betteridge DJ
    J Intern Med Suppl; 1994; 736():47-52. PubMed ID: 7986308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperlipidemia during diabetes mellitus. Recent developments].
    Guerci B; Ziegler O; Drouin P
    Presse Med; 1994 Jan; 23(2):82-8. PubMed ID: 8140078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors, endothelial cell turnover and lipid transport in atherogenesis.
    Lin SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):309-16. PubMed ID: 9037845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of dyslipidaemia despite adequate glycaemic control in patients with diabetes.
    Loh KC; Thai AC; Lui KF; Ng WY
    Ann Acad Med Singap; 1996 Mar; 25(2):228-32. PubMed ID: 8799011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.